Anti depressant drugs Flashcards

1
Q

what is depression

A

• Depression is characterized by intense feeling of sadness,
hopelessness, lack of motivation, despair, inability to experience
pleasure, changes in sleep and appetite, loss of energy, & suicidal
thoughts.
• Among emotional symptoms: Anxiety (in 90% of cases),
pessimistic outlook, and feeling of worthlessness.
• Among physical symptoms: Headache & palpitations, increased
sensitivity to painful stimuli.
• Among cognitive symptoms: Poor memory for recent events,
indecisiveness, psychotic features (auditory hallucination,
delusions).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the uses of antidepressants

A

1) Depression
2) Anxiety Disorders (PTSD, OCD, social anxiety disorder
and panic disorder)
3) Pain Disorders
4) Premenstrual Dysphoric Disorder: A combination of
emotional, physical, psychological, and mood disturbances
that occur after ovulation and normally end with the onset of
the menstrual flow.
5) Eating Disorders
• Bulimia nervosa: An eating disorder which is characterized
by intake of large amounts of food followed by self-induced
vomiting.
• Anorexia nervosa: Anorexia is a disorder in which reduced
food intake, and the person has a morbid fear of gaining
weight.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the uses of antidepressants

A

1) Depression
2) Anxiety Disorders (PTSD, OCD, social anxiety disorder
and panic disorder)
3) Pain Disorders
4) Premenstrual Dysphoric Disorder: A combination of
emotional, physical, psychological, and mood disturbances
that occur after ovulation and normally end with the onset of
the menstrual flow.
5) Eating Disorders
• Bulimia nervosa: An eating disorder which is characterized
by intake of large amounts of food followed by self-induced
vomiting.
• Anorexia nervosa: Anorexia is a disorder in which reduced
food intake, and the person has a morbid fear of gaining
weight.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the MOAs of anti depressants

A

• Biogenic amine theory: decreased brain levels of the
monoamines neurotransmitters norepinephrine (NE),
serotonin (5-HT), and dopamine (DA) may cause
depression
• Treatment of depression is centered on ↑:
• Serotonergic
• Noradrenergic
• &/or Dopaminergic neurotransmission.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are SSRIs

A

• MOA: block reuptake of serotonin.
• Replaced TCAs & MAOIs as 1st
-line therapy because less A/E & safer in overdose.
• Fluoxetine, citalopram, escitalopram, fluvoxamine, paroxetine, sertraline.
• Typically take at least 2 weeks to produce significant improvement in mood, and
maximum benefit may require up to 12 weeks or more.
• Patients that do not respond to one antidepressant may respond to another.
• Approximately 80% or more will respond to at least one antidepressant drug.
• SSRIs have little blocking activity at muscarinic, α-adrenergic, and histaminic H1
receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are SSRIs therapeutic uses

A

Major depression
-Obsessive compulsive disorder
-Panic disorder
-Premenstrual dysphoric disorder
-Generalized anxiety disorder,
-Posttraumatic stress disorder,
-Social anxiety disorder, and
-Bulimia nervosa (only fluoxetine is approved for bulimia).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the pharmacokinetics of SSRIs

A

• All of the SSRIs are well absorbed after oral administration.
• Food has little effect on absorption .
• The majority of SSRIs have plasma half-lives that range between 16
and 36 hours.
• Metabolism by CYP450–dependent enzymes.
• t1/2 of fluoxetine is long and is metabolized to an active metabolite.
• Fluoxetine is available as sustained-release preparation to be given
once a week: Prozac Weekly®.
• Fluoxetine & paroxetine are potent inhibitors of CYP2D6, which is
responsible for the elimination of TCAs, antipsychotic drugs, some
antiarrhythmic and β-adrenergic antagonist drugs.
• Dosages of the SSRIs should be reduced in patients with hepatic
impairment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the side effects of SSRIs

A

a) Sleep disturbances: insomnia, somnolence.
• Paroxetine & fluvoxamine are sedating and they may be useful in patients who
have difficulty sleeping.
• Fluoxetine & sertraline are activating for patients who are fatigued or
complaining of excessive somnolence.
b) Sexual dysfunction: which may include loss of libido, delayed ejaculation and
anorgasmia, is common with the SSRIs.
One option for managing SSRI-induced sexual dysfunction is to change the
antidepressant to one with fewer sexual side effects, such as bupropion or
mirtazapine. Alternatively, the dose of the drug may be reduced.
- Weakness, headache, anxiety (combined with a benzodiazepine for the first few
weeks to decrease anxiety).
- All antidepressants, but mostly SSRIs, can cause hyponatremia especially in the
elderly and patients who are volume depleted or taking diuretics.
Suicidality and antidepressant drugs: antidepressants increased the
risk of suicidal thinking and behavior (suicidality) in children,
adolescents, and young adults in short-term studies of major
depressive disorder (MDD) and other psychiatric disorders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the side effects of SSRIs

A

a) Sleep disturbances: insomnia, somnolence.
• Paroxetine & fluvoxamine are sedating and they may be useful in patients who
have difficulty sleeping.
• Fluoxetine & sertraline are activating for patients who are fatigued or
complaining of excessive somnolence.
b) Sexual dysfunction: which may include loss of libido, delayed ejaculation and
anorgasmia, is common with the SSRIs.
One option for managing SSRI-induced sexual dysfunction is to change the
antidepressant to one with fewer sexual side effects, such as bupropion or
mirtazapine. Alternatively, the dose of the drug may be reduced.
- Weakness, headache, anxiety (combined with a benzodiazepine for the first few
weeks to decrease anxiety).
- All antidepressants, but mostly SSRIs, can cause hyponatremia especially in the
elderly and patients who are volume depleted or taking diuretics.
Suicidality and antidepressant drugs: antidepressants increased the
risk of suicidal thinking and behavior (suicidality) in children,
adolescents, and young adults in short-term studies of major
depressive disorder (MDD) and other psychiatric disorders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what happens when you overdose on SSRI

A

Overdose with SSRIs does not usually cause cardiac arrhythmias, with the
exception of citalopram, which may cause QT prolongation.
• Seizures are a possibility.
• All SSRIs have the potential to cause serotonin syndrome, especially when used
in the presence of a MAOI or other highly serotonergic drug.
• Serotonin syndrome: shivering, diaphoresis, muscle rigidity, tachycardia,
hypertension, agitation, delirium, shock, (hyperthermia seizures, renal
failure).
• SSRIs should be spaced by weeks from MAOIs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how do we discontinue SSRIS (discontinuation syndrome)

A

• All of the SSRIs have the potential to cause a discontinuation syndrome after
their abrupt withdrawal, particularly the agents with shorter half-lives and
inactive metabolites. Fluoxetine has the lowest risk of causing an SSRI
discontinuation syndrome due to its longer half-life and active metabolite.
• SSRIs should be D/C gradually to avoid discontinuation symptoms that include
headache, flu-like symptoms, agitation, nervousness, and changes in sleep
pattern.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

For antidepressants in general:
1) Not effective for mild forms of depression
2) ↓ Dose of the antidepressant over (8 weeks - 6 months) to avoid
W/S if patient has been taking the drug for >8 weeks.
3) Effect is not prompt. It may take weeks before effect is seen. This
should be explained for the patient.
4) Weeks should be allowed as a wash-out period after cessation of
one antidepressant & the initiation of another.
5) No major teratogenic effects have been identified with the SSRIs
or TCAs. However, fluoxetine may cause premature birth & ↓ fetal
growth rate.
SSRIs are FDA pregnancy category C.
6) All antidepressants should be used with caution in patients with
bipolar disorder, even during their depressed state, because they
may cause a switch to manic behavior.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are SNRIs

A

• Venlafaxine, desvenlafaxine, and duloxetine.
• Can be effective in a patient who didn’t respond to SSRIs
• Also effective in relieving chronic pain (like backache and
muscle aches) that often accompanies depression and is
nonresponsive to SSRIs.
• Also for neuropathy of diabetes, postherpetic neuralgia,
fibromyalgia, and low back pain.
• The SNRIs have little activity at α-adrenergic, muscarinic, or
histamine receptors and, thus, have fewer of these receptor-
mediated adverse effects than the TCAs.
• The SNRIs may precipitate a discontinuation syndrome if
treatment is abruptly stopped.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are SNRIs

A

• Venlafaxine, desvenlafaxine, and duloxetine.
• Can be effective in a patient who didn’t respond to SSRIs
• Also effective in relieving chronic pain (like backache and
muscle aches) that often accompanies depression and is
nonresponsive to SSRIs.
• Also for neuropathy of diabetes, postherpetic neuralgia,
fibromyalgia, and low back pain.
• The SNRIs have little activity at α-adrenergic, muscarinic, or
histamine receptors and, thus, have fewer of these receptor-
mediated adverse effects than the TCAs.
• The SNRIs may precipitate a discontinuation syndrome if
treatment is abruptly stopped.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are Venlafaxine and desvenlafaxine:

A

Venlafaxine is a potent inhibitor of
serotonin reuptake and, at medium to higher doses, is an inhibitor of
norepinephrine reuptake (and serotonin)..
• Desvenlafaxine is the active, demethylated metabolite of venlafaxine.
• A/E: insomnia, sedation, constipation & hypertension (high dose). Fatal in
overdose.
• D/C syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is Duloxetine:

A

a serotonin & NE reuptake inhibitor at all doses.
• A/E similar to venlafaxine. Duloxetine may increase blood pressure or heart
rate.

15
Q

what are atypical antidepressants

A

bupropion, mirtazapine, nefazodone,
trazodone.

16
Q

what is Bupropion

A

Blocks DA & NE reuptake (weak).
• Used to alleviate the symptoms of depression. Also useful for
decreasing cravings and attenuating withdrawal of nicotine in
patients trying to quit smoking.
• A/E: dry mouth, sweating, nervousness, tremor, and a dose-
dependent increased risk for seizures. It has a very low incidence of
sexual dysfunction.
• C/I in patients at risk for seizures or those who have eating disorders
such as bulimia.

17
Q

what is Mirtazapine

A

Blocks presynaptic α2
-receptors ↑ serotonin & NE.
- It is sedating because of its potent antihistaminic activity.
- A/E: increased appetite and weight gain, but doesn’t cause sexual
dysfunction.
• Mirtazapine is markedly sedating, which may be an advantage in
depressed patients having difficulty sleeping.

18
Q

what is nefazodone and trazodone

A

Block serotonin reuptake and postsynaptic 5-HT2a receptors. These
two mechanisms may enhance 5-HT1A mediated
neurotransmission.
• Both agents are sedating, probably because of their potent
histamine H1
-blocking activity.
• Trazodone is commonly used off-label for the management of
insomnia.
- A/E: Sedation, dizziness and orthostatic hypotension (both
agents also have mild to moderate α1 receptor antagonism),

19
Q

what are TCAs MOA

A

Imipramine, amitriptyline, clomipramine, desipramine,
doxepin.
• A patient who doesn’t respond to one TCA may benefit from
another TCA.
A. Mode of action:
1. Inhibition of neurotransmitter uptake: serotonin & NE
2. Blocking of receptors: 5-HT, α-adrenergic, histamine, &
muscarinic receptors.
B. Actions: The TCAs elevate mood, improve mental alertness,
increase physical activity, and reduce morbid preoccupation in 50% to
70% of individuals with major depression. The onset of the mood
elevation is slow, requiring 2 weeks or longer

20
Q

what are the therapeutic uses for TCAs

A

Major depression
- Panic disorders
- Chronic neuropathic pain of unknown cause (including in diabetics).
- Imipramine: bed-wetting in children > 6, but replaced by desmopressin
and nonpharmacologic treatments (enuresis alarms).
- In low doses for irritable bowel syndrome.
• amitriptyline has been used to help prevent migraine headache.
- Low doses of TCAs, especially doxepin, can be used to treat insomnia.

21
Q

what are TCAs side effects

A

• Antimuscarinic effects, including blurred vision, xerostomia, urinary
retention, constipation, and exacerbation of glaucoma.
• Cardiac: cardiac overstimulation, reflex tachycardia, arrhythmia or slowing
of AV conduction & heart block!  an overdose can be fatal.
• Block α-adrenergic receptors, causing orthostatic hypotension, dizziness,
and reflex tachycardia
• Sedation: especially during first few weeks of treatment. this is required in
some depressive patients (block histamine H1 receptors).
• Weight gain.
• Less sexual dysfunction than SSRIs.
• TCAs may exacerbate certain medical conditions, such as benign
prostatic hyperplasia, epilepsy, and preexisting arrhythmias

Precautions:
TCAs (like all antidepressants) should be
used with caution in patients with bipolar
disorder, even during their depressed state,
because antidepressants may cause a switch
to manic behavior.
Narrow TI (e.g., 5 to 6 fold the maximal
daily dose of imipramine can be lethal).
 give only a limited supply to patients
with suicidal thoughts and monitor closely.
Drug Interactions:
Many drug interactions with different
mechanisms.

22
Q

what are MAOI MOA

A

In the neuron, MAO functions as a “safety valve” to oxidatively
deaminate and inactivate any excess neurotransmitters (e.g., NE, DA,
and 5-HT).
Tranylcypromine, phenylzine, isocarboxazid, selegiline.
Use of MAOIs is limited due to the complicated dietary restrictions
required while taking these agents.
A. MOA:
- Most MAOIs form stable complexes with the enzyme (brain, liver &
gut) causing irreversible inactivation→ ↑ stores of NE, 5-HT, & DA
within the neuron and subsequent diffusion of excess
neurotransmitter into the synaptic cleft.
- Tranylcypromine & phenylzine block MAO non-selectively.
These drugs inhibit MAO in the liver and gut that catalyzes oxidative
deamination of drugs and potentially toxic substances, such as
tyramine, which is found in certain foods.
• The MAOIs, therefore, show a high incidence of drug–drug and drug–
food interactions.
• Selegiline admininstered as transdermal patch → ↓inhibition of gut
and hepatic MAO at low doses because it avoids first-pass
metabolism.
B. Actions:
Antidepressant action of the MAOIs, like SSRIs, SNRIs &
TCAs, is delayed several weeks.
Selegiline & Tranylcpromine may produce agitation or
insomnia

23
Q

what are the therapeutic uses of MAOI

A

Major depression unresponsive to other antidepressants.
-Phobic disorders.
-Atypical depression involves several specific symptoms, including
increased appetite, excessive sleep, marked fatigue or weakness, and
feeling extremely sensitive to rejection.
MAOIs are considered LAST-LINE agents in many tt settings, due to their
risk of D-D and D-F interactions

24
Q

what are the kinetics of MAOIS

A

Oral administration
• MAOIs are hepatically metabolized and excreted rapidly in urine
• After stopping an MAOI, the body needs several weeks to regenerate
MAOs Wait a minimum 2 weeks before giving another antidepressant.

25
Q

what are the side effects of MAOI

A

E. Adverse effects:
• Postural hypotension, blurred vision, dry mouth, and constipation, &
sexual dysfunction in both genders.
• If a patient on an MAOI ingests tyramine hypertensive crisis. Its
symptoms: Occipital headache, stiff nick, ↑HR, cardiac arrhythmias,
hyperthermia, nausea, vomiting, sweating, ↑BP, seizures & stroke.
• Patients must be educated to avoid tyramine-containing foods*
*Aged cheeses & meats, chicken liver, pickled or smoked fish.
 Dangerous in severely depressed patients with suicidal tendency
• If a patient takes an MAOI with an SSRI serotonin syndrome
• MAOIs & other antidepressants is C/I.
• Both SSRIs and MAOIs require a washout period of at least 2 weeks
before the other type is administered, with the exception of
FLUOXETINE, which should be discontinued at least 6 weeks before
a MAOI is initiated.